维持性血液透析患者继发性甲状旁腺功能亢进症状的前瞻性队列研究
该前瞻性队列纳入165例维持性血液透析的继发性甲状旁腺功能亢进成人患者,随访24周,用自填问卷评估19种症状严重程度。结果显示PTH水平升高与骨痛、关节痛、肌肉酸痛、皮肤瘙痒和疲乏等症状加重相关(P<0.1)。结论需在其他人群中验证。
要点
- PTH升高与骨痛、关节痛、肌肉酸痛、瘙痒和疲乏加重相关。
- 关联强度随PTH变化幅度增大而更明显。
- 探索性研究,需外部验证后再用于临床监测。
核心结论
- 在继发性甲状旁腺功能亢进的血透患者中,PTH水平随时间升高与一个或多个症状簇的加重相关。
研究设计与样本
- 前瞻性队列研究,纳入165例美国单一透析提供者组织的维持性血透成人患者,随访24周。
主要发现
- PTH水平升高与骨痛和僵硬、关节痛、肌肉酸痛、整体疼痛、皮肤瘙痒和疲乏的加重相关(P<0.1)。
- PTH变化幅度越大,上述症状加重的效应越明显。
关键数值与推荐
- 暴露为24周内PTH水平变化,结局为19种推定症状,用自填问卷按5级有序量表评估严重程度,最多测量4次。
临床怎么用
- 可考虑将患者报告的症状(骨痛、关节痛、肌肉酸痛、瘙痒、疲乏)纳入继发性甲状旁腺功能亢进的临床监测。
局限性
- 可能存在未测量合并症和合并用药的混杂。
- 多重检验且P值阈值为0.10。
- 需在其他人群中重复验证后才能确定关联的幅度和形状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Although multiple lines of evidence suggest a negative impact of secondary hyperparathyroidism on patients with kidney failure treated by hemodialysis, it is uncertain whether patients can detect associated symptoms. The objective was to determine whether changes in parathyroid hormone (PTH) levels are associated with changes in symptoms within this patient population. STUDY DESIGN: Prospective cohort. SETTING & PARTICIPANTS: 165 adults with hyperparathyroidism secondary to kidney failure diagnosed, a range of dialysis vintages, and receiving regular hemodialysis from a US single-provider organization. EXPOSURE: Change in PTH levels over 24 weeks. OUTCOMES: 19 putative symptoms of secondary hyperparathyroidism measured up to 4 times using a self-administered questionnaire that assessed severity on a 5-level ordinal scale. ANALYTICAL APPROACH: Longitudinal associations between changes in PTH levels and symptom severity were assessed using generalized additive models. RESULTS: The 165 participants studied represented 81% of enrollees (N=204) who had sufficiently complete data for analysis. Mean age was 56 years and 54% were women. Increases in PTH levels over time were associated (P<0.1) with worsening of bone aches and stiffness, joint aches, muscle soreness, overall pain, itchy skin, and tiredness, and the effects were more pronounced with larger changes in PTH levels. LIMITATIONS: Findings may have been influenced by confounding by unmeasured comorbid conditions, concomitant medications, and multiple testing coupled with a P value threshold of 0.10. CONCLUSIONS: In this exploratory study, we observed that among patients with secondary hyperparathyroidism, increases in PTH levels over time were associated with worsening of 1 or more cluster of symptoms. Replication of these findings in other populations is needed before concluding about the magnitude and shape of these associations. If replicated, these findings could inform clinically useful approaches for measuring patient-reported outcomes related to secondary hyperparathyroidism.
引用
- Levy AR, Xing S, Brunelli SM, et al. Symptoms of Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: A Prospective Cohort Study. Am J Kidney Dis. 2019. PMID: 31629575. doi:10.1053/j.ajkd.2019.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。